medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2022, Number 2

<< Back

Rev Cubana Hematol Inmunol Hemoter 2022; 38 (2)

Sickle cell anemia: pathophysiology at a glance

Villaescusa BR

Language: Spanish
References: 17
Page: 1-3
PDF size: 300.55 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Kato G, Piel F, Reid C, Gaston M, Frempong K, Krishnamurti L, et al. Sickle cell disease. Nat Rev Dis Primers. 2018;4:1-22. DOI: https://doi.org/10.1038/nrdp.2018.101.

  2. Ware R, Montalembert M, Tshilolo L, Abboud M. Sickle cell disease. Lancet 2017;390:311-23. DOI: https://10.1016/s0140-6736(17)30193-92.

  3. Sundd P, Gladwin M, Novelli E. Pathophysiology of Sickle Cell Disease. 2019;14:263-92. DOI: https://10.1146/annurev-pathmechdis-012418-012838.623.

  4. Eaton W. Hemoglobin S polymerization and sickle cell disease: A retrospective on the occasion of the 70th anniversary of Pauling's Science paper. Am J Hematol. 2020;95:205-11. DOI: https://10.1002/ajh.256874.

  5. Darbari D, Sheehan V, Ballas S. The vaso-occlusive pain crisis in sickle cell disease: definition, pathophysiology, and management. Eur J Haematol. 2020;105(3):237-46. DOI: https://10.1111/ejh.13430455.

  6. Zhang D, Xu C, Manwani D, Frenette PS. Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology. Blood. 2016;127(7):801-9. DOI: https://10.1182/blood-2015-09-6185386.

  7. Conran N, Belcher JD. Inflammation in sickle cell disease. Clin Hemorheol Microcirc. 2018; 68:263-99. DOI: https://doi.org/10.3233/CH-1890127.

  8. Manwani D. P-selectin and sickle cell disease: a balancing act. Blood. 2021;137(19):2573-4. DOI: https://doi.org/10.1182/blood.20210111518.

  9. Bennewitz M, Tutuncuoglu E, Gudapati S, Brzoska T, Watkins S, Monga S, et al. P-selectin-deficient mice to study pathophysiology of sickle cell disease. Blood advances. 2020;4(2), 266-73. DOI: https://doi.org/10.1182/bloodadvances.20190006039.

  10. Shet A, Lizarralde-Iragorri M, Naik R. The molecular basis for the prothrombotic state in sickle cell disease. Haematologica. 2020;105(10):2368-79. DOI: https://10.3324/haematol.2019.23935010.

  11. Sparkenbaugh E, Pawlinsky R. Prothrombotic aspects of sickle cell disease. J Thromb Haemost. 2017;15:1307-16. DOI: https://doi.org/10.1111/jth.1371711.

  12. Hierso R, Lemonne N, Villaescusa R, Lalanne-Mistrih M-L, Charlot K, Etienne-Julan M, et al. Exacerbation of oxidative stress during sickle occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: a prospective study. Br J Haematol. 2017;176:805-13. DOI: https://10.1111/bjh.1447612.

  13. Villaescusa R. Banda 3: protagonismo en la oclusión vascular de la drepanocitosis. Rev Cubana Hematol Inmunol Hemoter. 2021 [acceso 22/04/2022];37(2):e1412. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892021000200001&lng=es13.

  14. Kato GJ, Steinberg MH, Gladwin MT. Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest. 2017;127(3):750-60 DOI: https://10.1172/JCI89741

  15. Connes P, Renoux C, Romana M, Abkarianf M, Joly P, Martin C, et al. Blood rheological abnormalities in sickle cell anemia. Clin Hemorheol Microcirc. 2018;68:165-72. DOI: https://doi.org/10.3233/CH-18900515.

  16. Reiter C, Wang X, Tanus-Santos J, Hogg N, Cannon R, Schechter A, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002;8(12):1383-9. DOI: https://10.1038/nm1202-79916.

  17. Hebbel R, Key N. Microparticles in sickle cell anaemia: promise and pitfalls. Br J Haematol. 2016;174(1):16-29. DOI: https://10.1111/bjh.1411217.




2020     |     www.medigraphic.com